Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market 2019 by Company, Regions, Type and Application, Forecast to 2024

Table of Contents

1 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Overview

• 1.1 Product Overview and Scope of Technologies for Delivery of Proteins, Antibodies and Nucleic Acids
• 1.2 Classification of Technologies for Delivery of Proteins, Antibodies and Nucleic Acids by Types
  • 1.2.1 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Comparison by Types (2019-2024)
  • 1.2.2 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Share by Types in 2018
  • 1.2.3 HEPtune® Technology
  • 1.2.4 Intravail® Technology
  • 1.2.5 RapidMist™
  • 1.2.6 TheraKine Technology
  • 1.2.7 Arestat™ Technology
  • 1.2.8 DelSiTech™ Silica Matrix
  • 1.2.9 ImSus® Technology
  • 1.2.10 PLEX™ Technology
  • 1.2.11 ENHANZE® Technology
• 1.3 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market by Application
  • 1.3.1 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size and Market Share Comparison by Applications (2014-2024)
  • 1.3.2 Delivery of Protein
  • 1.3.3 Delivery of Nucleic Acids
  • 1.3.4 Delivery Antibody
• 1.4 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market by Regions
  • 1.4.1 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size (Million USD) Comparison by Regions (2014-2024)
  • 1.4.1 North America (USA, Canada and Mexico) Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Status and Prospect (2014-2024)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy) Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Status and Prospect (2014-2024)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Status and Prospect (2014-2024)
  • 1.4.4 South America (Brazil, Argentina, Colombia) Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Status and Prospect (2014-2024)
  • 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Status and Prospect (2014-2024)
• 1.5 Global Market Size of Technologies for Delivery of Proteins, Antibodies and Nucleic Acids (2014-2024)

2 Company Profiles

• 2.1 Aphios
  • 2.1.1 Business Overview
  • 2.1.2 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Type and Applications
    • 2.1.2.1 Product A
    • 2.1.2.2 Product B
  • 2.1.3 Aphios Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, Gross Margin and Market Share (2017-2018)
• 2.2 Arbutus Biopharma
  • 2.2.1 Business Overview
  • 2.2.2 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Type and Applications
    • 2.2.2.1 Product A
    • 2.2.2.2 Product B
  • 2.2.3 Arbutus Biopharma Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, Gross Margin and Market Share (2017-2018)
• 2.3 Camurus
  • 2.3.1 Business Overview
  • 2.3.2 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Type and Applications
    • 2.3.2.1 Product A
    • 2.3.2.2 Product B
  • 2.3.3 Camurus Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, Gross Margin and Market Share (2017-2018)
• 2.4 ConjuChem
  • 2.4.1 Business Overview
  • 2.4.2 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Type and Applications
    • 2.4.2.1 Product A
    • 2.4.2.2 Product B
  • 2.4.3 ConjuChem Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, Gross Margin and Market Share (2017-2018)
• 2.5 InnoCore Pharmaceuticals
  • 2.5.1 Business Overview
  • 2.5.2 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Type and Applications
    • 2.5.2.1 Product A
    • 2.5.2.2 Product B
  • 2.5.3 InnoCore Pharmaceuticals Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, Gross Margin and Market Share (2017-2018)
• 2.6 LATITUDE Pharmaceuticals
  • 2.6.1 Business Overview
  • 2.6.2 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Type and Applications
    • 2.6.2.1 Product A
    • 2.6.2.2 Product B
  • 2.6.3 LATITUDE Pharmaceuticals Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue, Gross Margin and Market Share (2017-2018)

3 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Competition, by Players

• 3.1 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Share by Players (2014-2019)
• 3.2 Market Concentration Rate
  • 3.2.1 Top 5 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Players Market Share
  • 3.2.2 Top 10 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Players Market Share
• 3.3 Market Competition Trend

4 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size by Regions

• 4.1 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Market Share by Regions
• 4.2 North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)
• 4.3 Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)
• 4.4 Asia-Pacific Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)
• 4.5 South America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)
• 4.6 Middle East and Africa Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)

5 North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue by Countries

• 5.1 North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue by Countries (2014-2019)
• 5.2 USA Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)
• 5.3 Canada Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)
• 5.4 Mexico Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)

6 Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue by Countries

• 6.1 Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue by Countries (2014-2019)
• 6.2 Germany Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)
• 6.3 UK Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)
• 6.4 France Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)
• 6.5 Russia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)
• 6.6 Italy Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)

7 Asia-Pacific Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue by Countries

• 7.1 Asia-Pacific Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue by Countries (2014-2019)
• 7.2 China Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)
• 7.3 Japan Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)
• 7.4 Korea Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)
• 7.5 India Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)
• 7.6 Southeast Asia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)

8 South America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue by Countries

• 8.1 South America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue by Countries (2014-2019)
• 8.2 Brazil Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)
• 8.3 Argentina Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)
• 8.4 Colombia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)

9 Middle East and Africa Revenue Technologies for Delivery of Proteins, Antibodies and Nucleic Acids by Countries

• 9.1 Middle East and Africa Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue by Countries (2014-2019)
• 9.2 Saudi Arabia Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)
• 9.3 UAE Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)
• 9.4 Egypt Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)
• 9.5 Nigeria Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)
• 9.6 South Africa Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Growth Rate (2014-2019)

10 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Segment by Type

• 10.1 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue and Market Share by Type (2014-2019)
• 10.2 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Forecast by Type (2019-2024)
• 10.3 HEPtune® Technology Revenue Growth Rate (2014-2024)
• 10.4 Intravail® Technology Revenue Growth Rate (2014-2024)
• 10.5 RapidMist™ Revenue Growth Rate (2014-2024)
• 10.6 TheraKine Technology Revenue Growth Rate (2014-2024)
• 10.7 Arestat™ Technology Revenue Growth Rate (2014-2024)
• 10.8 DelSiTech™ Silica Matrix Revenue Growth Rate (2014-2024)
• 10.9 ImSus® Technology Revenue Growth Rate (2014-2024)
• 10.10 PLEX™ Technology Revenue Growth Rate (2014-2024)
• 10.11 ENHANZE® Technology Revenue Growth Rate (2014-2024)

11 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Segment by Application

• 11.1 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Share by Application (2014-2019)
• 11.2 Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Forecast by Application (2019-2024)
• 11.3 Delivery of Protein Revenue Growth (2014-2019)
• 11.4 Delivery of Nucleic Acids Revenue Growth (2014-2019)
• 11.5 Delivery Antibody Revenue Growth (2014-2019)

12 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size Forecast (2019-2024)

• 12.1 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Size Forecast (2019-2024)
• 12.2 Global Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Market Forecast by Regions (2019-2024)
• 12.3 North America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Forecast (2019-2024)
• 12.4 Europe Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Forecast (2019-2024)
• 12.5 Asia-Pacific Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Forecast (2019-2024)
• 12.6 South America Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Forecast (2019-2024)
• 12.7 Middle East and Africa Technologies for Delivery of Proteins, Antibodies and Nucleic Acids Revenue Market Forecast (2019-2024)

13 Research Findings and Conclusion

14 Appendix

• 14.1 Methodology